Jun 6, 2025
Barry Quart, CEO of Connect Biopharma, is developing the next generation of monoclonal antibodies targeting inflammatory respiratory diseases such as COPD and asthma. Administered subcutaneously, their lead program targets IL-4 and has demonstrated the ability to rapidly improve airway function and reduce the incidence...
Jun 6, 2025
Barry Quart, CEO of Connect Biopharma, is developing the next generation of monoclonal antibodies targeting inflammatory respiratory diseases such as COPD and asthma. Administered subcutaneously, their lead program targets IL-4 and has demonstrated the ability to rapidly improve airway function and reduce the incidence...
May 14, 2025
Chelsey Lindner, a pharmacist and Manager of Clinical Services at Shields Health Solutions, provides insights about the growing prevalence of oral and subcutaneous injection oncology medications, which is shifting the delivery of care from the clinic to at-home. This innovation in cancer care introduces...
May 14, 2025
Chelsey Lindner, a pharmacist and Manager of Clinical Services at Shields Health Solutions, provides insights about the growing prevalence of oral and subcutaneous injection oncology medications, which is shifting the delivery of care from the clinic to at-home. This innovation in cancer care introduces...
May 14, 2025
Chelsey Lindner, a pharmacist and Manager of Clinical Services at Shields Health Solutions, provides insights about the growing prevalence of oral and subcutaneous injection oncology medications, which is shifting the delivery of care from the clinic to at-home. This innovation in cancer care introduces...